213 related articles for article (PubMed ID: 29634130)
21. Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome.
Matsumoto S; Ueda T; Kakizaki H
Urology; 2013 Feb; 81(2):226-30. PubMed ID: 23374763
[TBL] [Abstract][Full Text] [Related]
22. [Complex local and central therapy of interstitial cystitis with devices AMUS-01-INTRAMAG and AMO-ATOS-E].
Rokhlokov IM; Raĭgorodskiĭ IuM; Timoshenko VO; Otradnov MV
Urologiia; 2011; (5):15, 17-20. PubMed ID: 22279780
[TBL] [Abstract][Full Text] [Related]
23. Stratification of Patients With Interstitial Cystitis/Bladder Pain Syndrome According to the Anatomical Bladder Capacity.
Mazeaud C; Rigaud J; Levesque A; Madec FX; Le Clerc QC; Wack M; Le Normand L; Riant T; Perrouin-Verbe MA
Urology; 2019 Jan; 123():87-92. PubMed ID: 30170094
[TBL] [Abstract][Full Text] [Related]
24. Intravesical tacrolimus in treatment of intractable interstitial cystitis/bladder pain syndrome - A pilot study.
Mishra NN; Riedl C; Shah S; Pathak N
Int J Urol; 2019 Jun; 26 Suppl 1():68-72. PubMed ID: 31144739
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trial.
Cvach K; Rosamilia A; Dwyer P; Lim Y; DeSouza A; Ow L; Thomas E; Murray C; Leitch A; Schierlitz L
Int Urogynecol J; 2021 May; 32(5):1177-1183. PubMed ID: 33452887
[TBL] [Abstract][Full Text] [Related]
26. Interstitial cystitis/bladder pain syndrome: diagnosis and management.
Offiah I; McMahon SB; O'Reilly BA
Int Urogynecol J; 2013 Aug; 24(8):1243-56. PubMed ID: 23430074
[TBL] [Abstract][Full Text] [Related]
27. Increased Transient Receptor Potential Melastatin 8 Expression in the Development of Bladder Pain in Patients With Interstitial Cystitis/Bladder Pain Syndrome.
Wu L; Zhang J; Zhou F; Zhang P
Urology; 2020 Dec; 146():301.e1-301.e6. PubMed ID: 33045289
[TBL] [Abstract][Full Text] [Related]
28. Clinical manifestations and results of cystoscopy in women with interstitial cystitis/bladder pain syndrome.
Sholan R
North Clin Istanb; 2020; 7(5):417-424. PubMed ID: 33163875
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Voiding Dysfunction Phenotypes in Women with Interstitial Cystitis/Bladder Pain and Myofascial Pelvic Pain: Results from the ICEPAC Trial.
Petrikovets A; Veizi IE; Hijaz A; Mahajan ST; Daneshgari F; Buffington CAT; McCabe P; Chelimsky T
Urology; 2019 Apr; 126():54-58. PubMed ID: 30682465
[TBL] [Abstract][Full Text] [Related]
30. Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy.
Aihara K; Hirayama A; Tanaka N; Fujimoto K; Yoshida K; Hirao Y
Int J Urol; 2009 Dec; 16(12):947-52. PubMed ID: 19817916
[TBL] [Abstract][Full Text] [Related]
31. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term outcomes and prognostic predictors.
Niimi A; Nomiya A; Yamada Y; Suzuki M; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Neurourol Urodyn; 2016 Nov; 35(8):965-969. PubMed ID: 26208131
[TBL] [Abstract][Full Text] [Related]
32. How are we going to make progress treating bladder pain syndrome? ICI-RS 2013.
Malykhina A; Hanno P
Neurourol Urodyn; 2014 Jun; 33(5):625-9. PubMed ID: 24615847
[TBL] [Abstract][Full Text] [Related]
33. Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction?
Tomoe H; Yamashita K
Arab J Urol; 2019 Mar; 17(1):77-81. PubMed ID: 31258947
[No Abstract] [Full Text] [Related]
34. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P
Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470
[TBL] [Abstract][Full Text] [Related]
36. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
Chiu B; Tai HC; Chung SD; Birder LA
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
[TBL] [Abstract][Full Text] [Related]
37. Improving clinical outcomes with lower motor voltage (≤3 V) during stage 1 sacral neuromodulation for interstitial cystitis or bladder pain syndrome.
Marinkovic SP
Neurourol Urodyn; 2019 Nov; 38(8):2233-2241. PubMed ID: 31512775
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of narrow band imaging-assisted transurethral electrocoagulation for ulcer-type interstitial cystitis/painful bladder syndrome.
Kajiwara M; Inoue S; Kobayashi K; Ohara S; Teishima J; Matsubara A
Int J Urol; 2014 Apr; 21 Suppl 1():57-60. PubMed ID: 24807500
[TBL] [Abstract][Full Text] [Related]
39. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
Liu HT; Kuo HC
Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097
[TBL] [Abstract][Full Text] [Related]
40. The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α.
Zhang J; Kang J; Wu L
Turk J Med Sci; 2024; 54(1):26-32. PubMed ID: 38812622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
